APA (7th ed.) Citation

He, B. (2021). Blockade of CD95/CD95L death signaling enhances CAR T cell persistence and antitumor efficacy.

Chicago Style (17th ed.) Citation

He, Bailin. Blockade of CD95/CD95L Death Signaling Enhances CAR T Cell Persistence and Antitumor Efficacy. Heidelberg, 2021.

MLA (9th ed.) Citation

He, Bailin. Blockade of CD95/CD95L Death Signaling Enhances CAR T Cell Persistence and Antitumor Efficacy. 2021.

Warning: These citations may not always be 100% accurate.